TrialEuropean journal of clinical pharmacology2017

A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects.

Pierre-Eric Juif et al.PubMed ↗Publisher ↗

No numbers read from the abstract.